Welcome to our dedicated page for The Beachbody news (Ticker: BODI), a resource for investors and traders seeking the latest updates and insights on The Beachbody stock.
The Beachbody Company, Inc. reports developments in fitness programming, nutrition products, supplements, and digital wellness subscriptions under the BODi brand. The company, formerly known as Beachbody, is associated with structured home fitness programs such as P90X, INSANITY and 21 Day Fix, as well as the Shakeology protein and superfood nutrition line.
Recurring updates cover new digital workout programs, nutrition-led product extensions, retail distribution for Shakeology, P90X-branded supplements, subscription offerings, and quarterly financial results. Company news also reflects BODi’s focus on combining fitness content, nutritional products, and community-based accountability for consumers seeking home-based health and wellness routines.
Beachbody (NASDAQ:BODI) announced participation in two upcoming investor conferences. Executives will present at LD Micro Invitational XVI in Los Angeles on May 18, 2026, at 1:30 p.m. PT with a live webcast. They will also hold 1x1 meetings at the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026.
BODi (NASDAQ:BODI) reported Q1 2026 revenue of $54.3 million, down from $72.4 million a year earlier, but exceeded the high end of guidance for revenue, net income and adjusted EBITDA.
Net income was $2.3 million versus a $5.7 million loss, and operating income reached $3.1 million versus a $3.7 million loss, marking a third consecutive profitable quarter on both metrics.
Adjusted EBITDA was $8.0 million, the tenth straight positive quarter, with gross margin at 71.8% and operating expenses reduced to $35.9 million.
Free cash flow was $(1.7) million. For Q2 2026, BODi guides revenue between $46 million and $51 million and adjusted EBITDA between $3 million and $6 million.
BODi (NASDAQ:BODI) announced a nationwide retail launch of its premium protein and superfood shake, Shakeology, at The Vitamin Shoppe locations later in 2026. The chain has over 640 stores, significantly increasing Shakeology’s brick-and-mortar presence.
Shakeology, introduced in 2009 and described as clinically studied, has generated over $4 billion in cumulative direct-to-consumer sales and more than 1 billion servings. The Vitamin Shoppe rollout follows upcoming distribution in 80+ Sprouts Farmers Market stores and supports BODi’s broader retail expansion strategy. Products will be sold in seven-serving bags at $34.99, initially in four flavors: Chocolate Whey, Vanilla Whey, Chocolate Vegan, and Vanilla Vegan.
BODi (NASDAQ: BODI) is launching Shakeology in over 80 Sprouts stores nationwide on May 18 and announced a strategic distribution partnership with KeHE, which can reach more than 30,000 retail locations. Shakeology is a 160-calorie protein and superfood shake, priced at $34.99 for a seven-serving bag.
The brand reports >$4 billion cumulative sales and 1 billion servings since 2009, offers whey and vegan formulas (17g and 16g protein), and cites a 12-week randomized clinical study in the Journal of Nutrition.
The Beachbody Company (NASDAQ: BODI) will release its first quarter 2026 results on Tuesday, May 12, 2026, after the U.S. market close. A conference call is scheduled the same day at 5:00 p.m. ET with dial-in and a live webcast.
The conference ID is 684011158. A webcast replay will be available on the investor relations site for one year.
BODi (NASDAQ: BODI) expanded its 10 Minute BODi catalogue on April 21, 2026, adding three targeted microdose programs: 10 Minute Speed Train, 10 Minute Active Aging, and 10 Minute GLP-1 Fitness Formula.
The tier offers over 400 ten-minute workouts, a $10/month subscription with a 10-day free trial, and ties to BODi nutrition products including Shakeology.
BODi (NASDAQ: BODI) launched a new line of P90X performance supplements on March 25, 2026, extending P90X Generation Next with science-backed formulations for workout performance, recovery, and daily energy.
Key products include P90X 100% Whey (25g protein/serving), P90X Creatine (5g creatine/serving), Pre-Workout, Hydration (1,155 mg electrolytes), and Energy sticks; formulas feature proprietary “P90X-Factor” blends. Products are available in multiple flavors and sold via BODi’s online shop; BODi subscription tiers start at $9.99/month, $19/month, or $179/year for full library access.
The Beachbody Company (NASDAQ: BODI) reported Q4 2025 revenue of $55.5M and full‑year 2025 revenue of $251.7M, with Q4 net income of $5.2M and FY net loss of $2.9M. The company delivered ninth consecutive quarter of positive adjusted EBITDA and its first full‑year operating income since IPO, with >$39M cash on hand.
Digital revenue was $34.3M in Q4 and digital subscriptions were 0.87M; gross margin improved to 74.5% in Q4 and 73.0% for the year.
BODi (NASDAQ: BODI) unveiled P90X Generation Next at "The P90X Factory" pop-up in New York on February 12, 2026, showcasing four live sessions led by Super Trainer Waz Ashayer.
The launch introduced a new P90X supplement line coming late March 2026 and highlighted subscription access: P90X single-program for $9.99/month, full library at $19/month or $179/year.
The Beachbody Company (NASDAQ: BODI) will release fourth-quarter 2025 results on Tuesday, March 10, 2026 after U.S. market close and will host a conference call at 5:00 p.m. ET. A live webcast will be available on the company's investor relations website.
Replay access will be provided March 10–17, 2026 with toll-free replay dial-in and passcode details supplied for investors.